Skip to content

San Bernardino Sun

57°F
Saturday, March 28th 2026

e-Edition

Trending:

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Provectus Biopharms (OP:PVCT)

0.0497 +0.0021 (+4.41%)
Streaming Delayed Price Updated: 3:59 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Provectus Biopharms

News headline image
PVCT Stock Earnings: Provectus Reported Results for Q2 2024 ↗
Provectus just reported results for the second quarter of 2024. 
Via InvestorPlace
News headline image
PVCT Stock Earnings: Provectus Reported Results for Q1 2024 ↗
Provectus just reported results for the first quarter of 2024. 
Via InvestorPlace
News headline image
PVCT Stock Earnings: Provectus Reported Results for Q4 2023 ↗
Provectus just reported results for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December ↗
On December 14th, the Federal Reserve hiked its key interest rate by 50 basis points. This was the first deceleration in rate hike increases in 2022; between March and November 2022, the interest rate... 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.